Live Breaking News & Updates on Immunotherapy Program

Stay updated with breaking news from Immunotherapy program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center

Dr. Lawrence Fong to lead Immunotherapy Integrated Research Center
fredhutch.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fredhutch.org Daily Mail and Mail on Sunday newspapers.

Stanford , California , United-states , Stanford-university , San-francisco , Sara-hurvitz , Geoffrey-hill , Fred-hutch , Lawrence-fong , University-of-washington-department-medicine , Immunotherapy-integrated-research-center , Immunotherapy-program

Dr Luke on the Background of the KEYNOTE-716 Trial in High-Risk Melanoma

Dr Luke on the Background of the KEYNOTE-716 Trial in High-Risk Melanoma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Jason-luke , Division-of-hematology-oncology , Cancer-immunotherapeutic-center , Immunotherapy-program , Hillman-cancer-center , Cancer-center ,

Luke Breaks Down Key Clinical Trial Updates From the 2023 ASCO Annual Meeting

Jason Luke, MD, FACP, discusses key takeaways from the KEYNOTE-716 and KEYNOTE-942 trials and other key updates from across the melanoma landscape presented at the 2023 ASCO Annual Meeting. ....

Pennsylvania , United-states , Jason-luke , Division-of-hematology-oncology , Cancer-immunotherapeutic-center , Hillman-cancer-center , Immunotherapy-program , European-medicines-agency , News-network , Cancer-center , Keynote-716 , Keynote-942

Spanish researchers develop new immunotherapy combination for liver cancer

Spanish researchers at Cima University of Navarra have developed a new immunotherapy combination that improves efficacy in animal models of hepatocellular carcinoma. This is a proof of concept that lays the foundations for the application of this treatment in patients with the most common liver cancer. ....

New-york , United-states , Teijeira , Galicia , Spain , Spanish , Lily-ramsey , Carmen-ochoa , Ignacio-melero , Saray-garasa , Amaia-lujambio , Cancer-center-cl

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma ....

Astellas-pharma , Immatics-incyte , Crown-bioscience , Jason-luke , Immunocore-incyte , Pembrolizumab-keytruda , Trex-bio , Codiak-biosciences , Bristol-myers-squibb , Serono , Novartis , Pfizer